|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses | |
| Research and development | |
| Sales and marketing | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income, net | |
| Income (loss) before income taxes | |
| Provision for (benefit from) income taxes | |
| Net income (loss) | |
| Less: net income attributable to participating securities | |
| Net income (loss) attributable to common stockholders | |
| Net income (loss) per share, basic and diluted: | |
| Net income (loss) per share, basic (in usd per share) | |
| Net income (loss) per share, diluted (in usd per share) | |
| Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, basic (in shares) | |
| Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) |
Loading...
